Global Losartan Potassium Market Research Report 2023
Global Losartan Potassium Market Overview:
Global Losartan Potassium Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Losartan Potassium involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Losartan Potassium Market
The Losartan Potassium Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Losartan Potassium Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Losartan Potassium Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Losartan Potassium Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Losartan Potassium market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Losartan Potassium Market Segmentation
Global Losartan Potassium Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Losartan Potassium market has been segmented into:
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
By Application, Losartan Potassium market has been segmented into:
Research
Pharmaceutical
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Losartan Potassium market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Losartan Potassium market.
Top Key Players Covered in Losartan Potassium market are:
Roxane
Merck Sharp & Dohme Chibret
Lupin
Upsher Smith
Aurobindo Pharma
Torrent Pharms
Sandoz
Lek S.A
Vivimed Labs
Zydus Pharms
Hanmi Fine Chemical
Actavis
Alembic Pharms
Teva
Objective to buy this Report:
1. Losartan Potassium analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Losartan Potassium market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Losartan Potassium Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Losartan Potassium involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Losartan Potassium Market
The Losartan Potassium Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Losartan Potassium Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Losartan Potassium Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Losartan Potassium Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Losartan Potassium market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Losartan Potassium Market Segmentation
Global Losartan Potassium Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Losartan Potassium market has been segmented into:
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
By Application, Losartan Potassium market has been segmented into:
Research
Pharmaceutical
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Losartan Potassium market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Losartan Potassium market.
Top Key Players Covered in Losartan Potassium market are:
Roxane
Merck Sharp & Dohme Chibret
Lupin
Upsher Smith
Aurobindo Pharma
Torrent Pharms
Sandoz
Lek S.A
Vivimed Labs
Zydus Pharms
Hanmi Fine Chemical
Actavis
Alembic Pharms
Teva
Objective to buy this Report:
1. Losartan Potassium analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Losartan Potassium market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: LOSARTAN POTASSIUM MARKET BY TYPE
5.1 Losartan Potassium Market Overview Snapshot and Growth Engine
5.2 Losartan Potassium Market Overview
5.3 Min Purity Less Than 98%
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Min Purity Less Than 98%: Geographic Segmentation
5.4 Min Purity 98%-99%
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Min Purity 98%-99%: Geographic Segmentation
5.5 Min Purity More Than 99%
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Min Purity More Than 99%: Geographic Segmentation
CHAPTER 6: LOSARTAN POTASSIUM MARKET BY APPLICATION
6.1 Losartan Potassium Market Overview Snapshot and Growth Engine
6.2 Losartan Potassium Market Overview
6.3 Research
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Research: Geographic Segmentation
6.4 Pharmaceutical
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Losartan Potassium Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Losartan Potassium Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Losartan Potassium Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ROXANE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MERCK SHARP & DOHME CHIBRET
7.4 LUPIN
7.5 UPSHER SMITH
7.6 AUROBINDO PHARMA
7.7 TORRENT PHARMS
7.8 SANDOZ
7.9 LEK S.A
7.10 VIVIMED LABS
7.11 ZYDUS PHARMS
7.12 HANMI FINE CHEMICAL
7.13 ACTAVIS
7.14 ALEMBIC PHARMS
7.15 TEVA
CHAPTER 8: GLOBAL LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Min Purity Less Than 98%
8.2.2 Min Purity 98%-99%
8.2.3 Min Purity More Than 99%
8.3 Historic and Forecasted Market Size By Application
8.3.1 Research
8.3.2 Pharmaceutical
CHAPTER 9: NORTH AMERICA LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Min Purity Less Than 98%
9.4.2 Min Purity 98%-99%
9.4.3 Min Purity More Than 99%
9.5 Historic and Forecasted Market Size By Application
9.5.1 Research
9.5.2 Pharmaceutical
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Min Purity Less Than 98%
10.4.2 Min Purity 98%-99%
10.4.3 Min Purity More Than 99%
10.5 Historic and Forecasted Market Size By Application
10.5.1 Research
10.5.2 Pharmaceutical
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Min Purity Less Than 98%
11.4.2 Min Purity 98%-99%
11.4.3 Min Purity More Than 99%
11.5 Historic and Forecasted Market Size By Application
11.5.1 Research
11.5.2 Pharmaceutical
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Min Purity Less Than 98%
12.4.2 Min Purity 98%-99%
12.4.3 Min Purity More Than 99%
12.5 Historic and Forecasted Market Size By Application
12.5.1 Research
12.5.2 Pharmaceutical
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Min Purity Less Than 98%
13.4.2 Min Purity 98%-99%
13.4.3 Min Purity More Than 99%
13.5 Historic and Forecasted Market Size By Application
13.5.1 Research
13.5.2 Pharmaceutical
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: LOSARTAN POTASSIUM MARKET BY TYPE
5.1 Losartan Potassium Market Overview Snapshot and Growth Engine
5.2 Losartan Potassium Market Overview
5.3 Min Purity Less Than 98%
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Min Purity Less Than 98%: Geographic Segmentation
5.4 Min Purity 98%-99%
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Min Purity 98%-99%: Geographic Segmentation
5.5 Min Purity More Than 99%
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Min Purity More Than 99%: Geographic Segmentation
CHAPTER 6: LOSARTAN POTASSIUM MARKET BY APPLICATION
6.1 Losartan Potassium Market Overview Snapshot and Growth Engine
6.2 Losartan Potassium Market Overview
6.3 Research
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Research: Geographic Segmentation
6.4 Pharmaceutical
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Losartan Potassium Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Losartan Potassium Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Losartan Potassium Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ROXANE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MERCK SHARP & DOHME CHIBRET
7.4 LUPIN
7.5 UPSHER SMITH
7.6 AUROBINDO PHARMA
7.7 TORRENT PHARMS
7.8 SANDOZ
7.9 LEK S.A
7.10 VIVIMED LABS
7.11 ZYDUS PHARMS
7.12 HANMI FINE CHEMICAL
7.13 ACTAVIS
7.14 ALEMBIC PHARMS
7.15 TEVA
CHAPTER 8: GLOBAL LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Min Purity Less Than 98%
8.2.2 Min Purity 98%-99%
8.2.3 Min Purity More Than 99%
8.3 Historic and Forecasted Market Size By Application
8.3.1 Research
8.3.2 Pharmaceutical
CHAPTER 9: NORTH AMERICA LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Min Purity Less Than 98%
9.4.2 Min Purity 98%-99%
9.4.3 Min Purity More Than 99%
9.5 Historic and Forecasted Market Size By Application
9.5.1 Research
9.5.2 Pharmaceutical
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Min Purity Less Than 98%
10.4.2 Min Purity 98%-99%
10.4.3 Min Purity More Than 99%
10.5 Historic and Forecasted Market Size By Application
10.5.1 Research
10.5.2 Pharmaceutical
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Min Purity Less Than 98%
11.4.2 Min Purity 98%-99%
11.4.3 Min Purity More Than 99%
11.5 Historic and Forecasted Market Size By Application
11.5.1 Research
11.5.2 Pharmaceutical
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Min Purity Less Than 98%
12.4.2 Min Purity 98%-99%
12.4.3 Min Purity More Than 99%
12.5 Historic and Forecasted Market Size By Application
12.5.1 Research
12.5.2 Pharmaceutical
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA LOSARTAN POTASSIUM MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Min Purity Less Than 98%
13.4.2 Min Purity 98%-99%
13.4.3 Min Purity More Than 99%
13.5 Historic and Forecasted Market Size By Application
13.5.1 Research
13.5.2 Pharmaceutical
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. LOSARTAN POTASSIUM MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. LOSARTAN POTASSIUM MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. LOSARTAN POTASSIUM MARKET COMPETITIVE RIVALRY
TABLE 005. LOSARTAN POTASSIUM MARKET THREAT OF NEW ENTRANTS
TABLE 006. LOSARTAN POTASSIUM MARKET THREAT OF SUBSTITUTES
TABLE 007. LOSARTAN POTASSIUM MARKET BY TYPE
TABLE 008. MIN PURITY LESS THAN 98% MARKET OVERVIEW (2016-2028)
TABLE 009. MIN PURITY 98%-99% MARKET OVERVIEW (2016-2028)
TABLE 010. MIN PURITY MORE THAN 99% MARKET OVERVIEW (2016-2028)
TABLE 011. LOSARTAN POTASSIUM MARKET BY APPLICATION
TABLE 012. RESEARCH MARKET OVERVIEW (2016-2028)
TABLE 013. PHARMACEUTICAL MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 016. N LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 019. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 022. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 025. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 028. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 029. ROXANE: SNAPSHOT
TABLE 030. ROXANE: BUSINESS PERFORMANCE
TABLE 031. ROXANE: PRODUCT PORTFOLIO
TABLE 032. ROXANE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. MERCK SHARP & DOHME CHIBRET: SNAPSHOT
TABLE 033. MERCK SHARP & DOHME CHIBRET: BUSINESS PERFORMANCE
TABLE 034. MERCK SHARP & DOHME CHIBRET: PRODUCT PORTFOLIO
TABLE 035. MERCK SHARP & DOHME CHIBRET: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. LUPIN: SNAPSHOT
TABLE 036. LUPIN: BUSINESS PERFORMANCE
TABLE 037. LUPIN: PRODUCT PORTFOLIO
TABLE 038. LUPIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. UPSHER SMITH: SNAPSHOT
TABLE 039. UPSHER SMITH: BUSINESS PERFORMANCE
TABLE 040. UPSHER SMITH: PRODUCT PORTFOLIO
TABLE 041. UPSHER SMITH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. AUROBINDO PHARMA: SNAPSHOT
TABLE 042. AUROBINDO PHARMA: BUSINESS PERFORMANCE
TABLE 043. AUROBINDO PHARMA: PRODUCT PORTFOLIO
TABLE 044. AUROBINDO PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. TORRENT PHARMS: SNAPSHOT
TABLE 045. TORRENT PHARMS: BUSINESS PERFORMANCE
TABLE 046. TORRENT PHARMS: PRODUCT PORTFOLIO
TABLE 047. TORRENT PHARMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. SANDOZ: SNAPSHOT
TABLE 048. SANDOZ: BUSINESS PERFORMANCE
TABLE 049. SANDOZ: PRODUCT PORTFOLIO
TABLE 050. SANDOZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. LEK S.A: SNAPSHOT
TABLE 051. LEK S.A: BUSINESS PERFORMANCE
TABLE 052. LEK S.A: PRODUCT PORTFOLIO
TABLE 053. LEK S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. VIVIMED LABS: SNAPSHOT
TABLE 054. VIVIMED LABS: BUSINESS PERFORMANCE
TABLE 055. VIVIMED LABS: PRODUCT PORTFOLIO
TABLE 056. VIVIMED LABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ZYDUS PHARMS: SNAPSHOT
TABLE 057. ZYDUS PHARMS: BUSINESS PERFORMANCE
TABLE 058. ZYDUS PHARMS: PRODUCT PORTFOLIO
TABLE 059. ZYDUS PHARMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. HANMI FINE CHEMICAL: SNAPSHOT
TABLE 060. HANMI FINE CHEMICAL: BUSINESS PERFORMANCE
TABLE 061. HANMI FINE CHEMICAL: PRODUCT PORTFOLIO
TABLE 062. HANMI FINE CHEMICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. ACTAVIS: SNAPSHOT
TABLE 063. ACTAVIS: BUSINESS PERFORMANCE
TABLE 064. ACTAVIS: PRODUCT PORTFOLIO
TABLE 065. ACTAVIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. ALEMBIC PHARMS: SNAPSHOT
TABLE 066. ALEMBIC PHARMS: BUSINESS PERFORMANCE
TABLE 067. ALEMBIC PHARMS: PRODUCT PORTFOLIO
TABLE 068. ALEMBIC PHARMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. TEVA: SNAPSHOT
TABLE 069. TEVA: BUSINESS PERFORMANCE
TABLE 070. TEVA: PRODUCT PORTFOLIO
TABLE 071. TEVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. LOSARTAN POTASSIUM MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. LOSARTAN POTASSIUM MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. LOSARTAN POTASSIUM MARKET COMPETITIVE RIVALRY
TABLE 005. LOSARTAN POTASSIUM MARKET THREAT OF NEW ENTRANTS
TABLE 006. LOSARTAN POTASSIUM MARKET THREAT OF SUBSTITUTES
TABLE 007. LOSARTAN POTASSIUM MARKET BY TYPE
TABLE 008. MIN PURITY LESS THAN 98% MARKET OVERVIEW (2016-2028)
TABLE 009. MIN PURITY 98%-99% MARKET OVERVIEW (2016-2028)
TABLE 010. MIN PURITY MORE THAN 99% MARKET OVERVIEW (2016-2028)
TABLE 011. LOSARTAN POTASSIUM MARKET BY APPLICATION
TABLE 012. RESEARCH MARKET OVERVIEW (2016-2028)
TABLE 013. PHARMACEUTICAL MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 016. N LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 019. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 022. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 025. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA LOSARTAN POTASSIUM MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA LOSARTAN POTASSIUM MARKET, BY APPLICATION (2016-2028)
TABLE 028. LOSARTAN POTASSIUM MARKET, BY COUNTRY (2016-2028)
TABLE 029. ROXANE: SNAPSHOT
TABLE 030. ROXANE: BUSINESS PERFORMANCE
TABLE 031. ROXANE: PRODUCT PORTFOLIO
TABLE 032. ROXANE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. MERCK SHARP & DOHME CHIBRET: SNAPSHOT
TABLE 033. MERCK SHARP & DOHME CHIBRET: BUSINESS PERFORMANCE
TABLE 034. MERCK SHARP & DOHME CHIBRET: PRODUCT PORTFOLIO
TABLE 035. MERCK SHARP & DOHME CHIBRET: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. LUPIN: SNAPSHOT
TABLE 036. LUPIN: BUSINESS PERFORMANCE
TABLE 037. LUPIN: PRODUCT PORTFOLIO
TABLE 038. LUPIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. UPSHER SMITH: SNAPSHOT
TABLE 039. UPSHER SMITH: BUSINESS PERFORMANCE
TABLE 040. UPSHER SMITH: PRODUCT PORTFOLIO
TABLE 041. UPSHER SMITH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. AUROBINDO PHARMA: SNAPSHOT
TABLE 042. AUROBINDO PHARMA: BUSINESS PERFORMANCE
TABLE 043. AUROBINDO PHARMA: PRODUCT PORTFOLIO
TABLE 044. AUROBINDO PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. TORRENT PHARMS: SNAPSHOT
TABLE 045. TORRENT PHARMS: BUSINESS PERFORMANCE
TABLE 046. TORRENT PHARMS: PRODUCT PORTFOLIO
TABLE 047. TORRENT PHARMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. SANDOZ: SNAPSHOT
TABLE 048. SANDOZ: BUSINESS PERFORMANCE
TABLE 049. SANDOZ: PRODUCT PORTFOLIO
TABLE 050. SANDOZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. LEK S.A: SNAPSHOT
TABLE 051. LEK S.A: BUSINESS PERFORMANCE
TABLE 052. LEK S.A: PRODUCT PORTFOLIO
TABLE 053. LEK S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. VIVIMED LABS: SNAPSHOT
TABLE 054. VIVIMED LABS: BUSINESS PERFORMANCE
TABLE 055. VIVIMED LABS: PRODUCT PORTFOLIO
TABLE 056. VIVIMED LABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ZYDUS PHARMS: SNAPSHOT
TABLE 057. ZYDUS PHARMS: BUSINESS PERFORMANCE
TABLE 058. ZYDUS PHARMS: PRODUCT PORTFOLIO
TABLE 059. ZYDUS PHARMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. HANMI FINE CHEMICAL: SNAPSHOT
TABLE 060. HANMI FINE CHEMICAL: BUSINESS PERFORMANCE
TABLE 061. HANMI FINE CHEMICAL: PRODUCT PORTFOLIO
TABLE 062. HANMI FINE CHEMICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. ACTAVIS: SNAPSHOT
TABLE 063. ACTAVIS: BUSINESS PERFORMANCE
TABLE 064. ACTAVIS: PRODUCT PORTFOLIO
TABLE 065. ACTAVIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. ALEMBIC PHARMS: SNAPSHOT
TABLE 066. ALEMBIC PHARMS: BUSINESS PERFORMANCE
TABLE 067. ALEMBIC PHARMS: PRODUCT PORTFOLIO
TABLE 068. ALEMBIC PHARMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. TEVA: SNAPSHOT
TABLE 069. TEVA: BUSINESS PERFORMANCE
TABLE 070. TEVA: PRODUCT PORTFOLIO
TABLE 071. TEVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. LOSARTAN POTASSIUM MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. LOSARTAN POTASSIUM MARKET OVERVIEW BY TYPE
FIGURE 012. MIN PURITY LESS THAN 98% MARKET OVERVIEW (2016-2028)
FIGURE 013. MIN PURITY 98%-99% MARKET OVERVIEW (2016-2028)
FIGURE 014. MIN PURITY MORE THAN 99% MARKET OVERVIEW (2016-2028)
FIGURE 015. LOSARTAN POTASSIUM MARKET OVERVIEW BY APPLICATION
FIGURE 016. RESEARCH MARKET OVERVIEW (2016-2028)
FIGURE 017. PHARMACEUTICAL MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. LOSARTAN POTASSIUM MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. LOSARTAN POTASSIUM MARKET OVERVIEW BY TYPE
FIGURE 012. MIN PURITY LESS THAN 98% MARKET OVERVIEW (2016-2028)
FIGURE 013. MIN PURITY 98%-99% MARKET OVERVIEW (2016-2028)
FIGURE 014. MIN PURITY MORE THAN 99% MARKET OVERVIEW (2016-2028)
FIGURE 015. LOSARTAN POTASSIUM MARKET OVERVIEW BY APPLICATION
FIGURE 016. RESEARCH MARKET OVERVIEW (2016-2028)
FIGURE 017. PHARMACEUTICAL MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA LOSARTAN POTASSIUM MARKET OVERVIEW BY COUNTRY (2016-2028)
